Referenzen
Produkte Transfektion
Kostenlose Testsamples
Anwendungshinweise:
Im „Transfection Reagent Selection Guide“ können Sie durch Filterfunktionen z.B. für Ihre Kombination aus zu transfizierender Zelle und Nukleinsäure die Liste vorhandener Referenzen durchsuchen. Ebenso können Sie im Feld „Referenzen durchsuchen“ am Anfang der Seite mit passenden Schlagwörtern zu einem Ergebnis gelangen. Eine Referenz zeigt an, dass das gefundene Transfektionsreagenz bereits erfolgreich für die entsprechende Anwendung verwendet wurde. Im Idealfall sind getestete Transfektionsparameter und Transfektionseffizienzen angegeben.
Keine Referenz? > Allgemeine Auswahlhilfe
Wenn Sie keine Referenz gefunden haben, heißt das nicht, dass kein passendes Reagenz zur Verfügung steht, sondern lediglich, dass bisher keine Erfahrungsberichte vorliegen. In diesem Falle kann durch eine Vorauswahl ein erfolgsversprechendes Transfektionsreagenz ausgewählt (Allgemeine Auswahlhilfe) und letztendlich ausgetestet (Kostenlose Testsamples) werden. Wenn Sie einen Erfahrungsbericht für uns schreiben möchten machen wir Ihnen ein Angebot für eine Gegenleistung.
CELL TYPE | DESCRIPTION OF CELL TYPE | CAT.NO. | SPECIES | ORIGIN OF CELLS | COMMON CELL TYPE | GROWTH PROPERTIES | NUCLEIC ACID / DELIVERED MOLECULE | APPLICATION | PRODUCT | REFERENCE TYPE | BIBLIOGRAPHIC DATA | LINK | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
RAW 264.7 |
Mouse leukaemic monocyte/macrophage cell line | ATCC TIB-71 | Mouse | unknown | cell line | adherent | plasmid | RNA-Interference | Metafectene PRO | publication | K.-H. Kim et al., Chem. Res. Toxicol., 2015, 28: 71−86; DOI: 10.1021/tx500341z | ||
RAW 264.7 |
Mouse leukaemic monocyte/macrophage cell line | ATCC TIB-71 | Mouse | unknown | cell line | adherent | siRNA | RNA-Interference | Metafectene SI | publication | S. Kim et al, J. Immunol., May 2015; 194: 4498 - 4506 | Link | |
RAW 264.7 |
Mouse leukaemic monocyte/macrophage cell line | ATCC TIB-71 | Mouse | unknown | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | E. Xu et al., Journal of Proteomics, 2015, 128: 30-38; doi.org/10.1016/j.jprot.2015.07.003 | ||
Rat VSMC |
Rat (Wistar) vascular smooth muscle cells from thoracic aorta | Rat | vasculature | unknown | siRNA | RNA-Interference | Metafectene | publication | A. Giordano et al., Am J Physiol Heart Circ Physiol, Jun 2006; 290: H2459 - H2465 | Link | |||
Rat DRG neurons |
Rat primary dorsal root ganglia neurons | Rat | nervous system | primary cell | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | D. S. M. Nascimento et al., Mol. Neurobiol., 2018, 55: 3959–3975, DOI 10.1007/s12035-017-0628-x | |||
Rat DRG neurons |
Rat neurons isolated from the DRG | Rat | nervous system | primary cell | adherent | siRNA | RNA-Interference | Metafectene | publication | C. Li et al., J. of Neuroinflammation, 2014, DOI 10.1186/s12974-015-0286-8 | |||
PM-WK |
Human skin malignant melanoma cell line | ATCC CRL-2624 | Human | skin | cell line | adherent | plasmid | RNA-Interference | Metafectene | publication | A. Renziehausen et al., Oncogene, 2019, 38:2320–2336, doi.org/10.1038/s41388-018-0563-y | ||
Phoenix |
Retrovirus producer cell line (Derivat of 293T) | Human | urinary system | cell line | adherent | siRNA | RNA-Interference | Metafectene SI | publication | E. Bernardinelli et al., PLOSONE, doi.org/10.1371/journal.pone.0179591 | Link | ||
Phoenix |
Retrovirus producer cell line (Derivat of 293T) | Human | urinary system | cell line | adherent | siRNA | RNA-Interference | Metafectene SI | publication | S. Dossena et al., J. Biol. Chem., Nov 2011; 286: 40659 - 40670 | Link | ||
pHDF |
Human primary dermal fibroblasts | Human | skin | primary cell | adherent | siRNA | RNA-Interference | K2 Transfection System | publication | E. A. Ostrakhovitch et al., Exp. Cell Res., 2019, 385: 111683, doi.org/10.1016/j.yexcr.2019.111683 | Link | ||
pHDF |
Human primary dermal fibroblasts | Human | skin | primary cell | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | E. Pesarchuk, 2016, Dissertation, Universtity of Vancouver | Link | ||
pHDF |
Human primary dermal fibroblasts | Human | skin | primary cell | adherent | siRNA | RNA-Interference | K2 Transfection System | publication | E. A. Ostrakhovitch et al., PLoS ONE, 2020, 15(11): e0241685, doi.org/10.1371/journal.pone.0241685 | Link | ||
pHDF |
Human primary dermal fibroblasts | Human | skin | primary cell | adherent | siRNA | RNA-Interference | K2 Transfection System | application note | ![]() |
|||
PC-3M |
Human prostate carcinoma cell line | Human | genital tract | cell line | adherent | plasmid | RNA-Interference | Metafectene | publication | A. L. Omara-Opyene et al., Lab Invest., 2004 Jul; 84(7):894-907 | |||
PC-3 |
Human prostate cancer cell line | ATCC CRL-1435 | Human | genital tract | cell line | adherent | siRNA | RNA-Interference | Metafectene SI | publication | M. B. Morelli et al., BMC Cancer, 2014, 14:921, doi:10.1186/1471-2407-14-921 | Link | |
PC-3 |
Human prostate cancer cell line | ATCC CRL-1435 | Human | genital tract | cell line | adherent | siRNA | RNA-Interference | Metafectene | application note | ![]() |
||
PC-3 |
Human prostate cancer cell line | ATCC CRL-1435 | Human | genital tract | cell line | adherent | plasmid | RNA-Interference | Metafectene | publication | U. K. Mukhopadhyay et al., Cancer Res., Apr 2005; 65: 2872 - 2881 | Link | |
PC-3 |
Human prostate cancer cell line | ATCC CRL-1435 | Human | genital tract | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | E. Werwein et al., Nucleic Acids Res., 2019, 47(1): 103–121, doi: 10.1093/nar/gky935 | Link | |
PC-3 |
Human prostate cancer cell line | ATCC CRL-1435 | Human | genital tract | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | S. Steinmann et al., J. Biol. Chem., Vol. 288, No. 31, pp. 22257–22269, August 2, 2013 | Link | |
PC-3 |
Human prostate cancer cell line | ATCC CRL-1435 | Human | genital tract | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | U. Weirauch et al., Nucleic Acid Therapeutics, 2013, 23 (4): 264-272, DOI: 10.1089/nat.2012.0407 | Link | |
PC-12 |
Rat adrenal gland cell line | ATCC CRL-1721 | Rat | other | cell line | suspension | siRNA | RNA-Interference | Metafectene PRO | publication | A. Morch, Dissertation, 2019, Ernst-Moritz-Arndt Universität Greifswald | ||
PC-12 |
Rat adrenal gland cell line | ATCC CRL-1721 | Rat | other | cell line | suspension | siRNA | RNA-Interference | Metafectene PRO | publication | F. Martorana et al., Cell Death and Disease, 2018, 9:391; DOI 10.1038/s41419-018-0429-9 | Link | |
PBMC |
Human CD8+ T cells isolated from peripheral blood mononuclear cells | Human | immune system | unknown | siRNA | RNA-Interference | Metafectene PRO | application note | ![]() |
||||
pBAEC |
Bovine primary aortic endothelial cells | Cow | vasculature | primary cell | adherent | siRNA | RNA-Interference | Metafectene | publication | Y. Riahi et al., Diabetes, Apr 2010; 59: 808 - 818 | Link | ||
Panc-1 |
Human exocrine pancreas carcinoma cells | ATCC CRL-1469 | Human | digestive organs | cell line | adherent | siRNA | RNA-Interference | Metafectene SI | publication | A. D. Konitsiotis et al., PLoS ONE, 2014, 9(3): e89899, doi:10.1371/journal.pone.0089899 | Link |